LOPERAMIDE EG CONSEIL 2 mg, orodispersible tablet 12 tablets
Active ingredients: Loperamide hydrochloride
Commercialized according to BDPM
Orodispersible tablet12 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOPERAMIDE EG CONSEIL 2 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 12 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Mar 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66227760CIP73018323CIP133400930183236Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LOPÉRAMIDEcomprimé | 2,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.